Ionis Pharmaceuticals (IONS)

Ionis Pharmaceuticals (IONS) Stock Price & Analysis


IONS Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$32.69 - $50.39
Previous Close$49.7
Average Volume (3M)1.06M
Market Cap
Enterprise Value$5.09B
Total Cash (Recent Filing)$2.24B
Total Debt (Recent Filing)$173.04M
Price to Earnings (P/E)-17.4
Feb 22, 2024
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.86
Shares Outstanding143,472,119
10 Day Avg. Volume886,600
30 Day Avg. Volume1,063,252
Standard Deviation0.09
Financial Highlights & Ratios
Price to Book (P/B)22.66
Price to Sales (P/S)8.80
Price to Cash Flow (P/CF)-16.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue9.47
Enterprise Value/Gross Profit8.87
Enterprise Value/Ebitda-15.05
Price Target Upside9.64% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering16



Ownership Overview

36.58% Mutual Funds
54.69% Other Institutional Investors
7.77% Public Companies and
Individual Investors


What was Ionis Pharmaceuticals’s price range in the past 12 months?
Ionis Pharmaceuticals lowest stock price was $32.69 and its highest was $50.39 in the past 12 months.
    What is Ionis Pharmaceuticals’s market cap?
    Currently, no data Available
    When is Ionis Pharmaceuticals’s upcoming earnings report date?
    Ionis Pharmaceuticals’s upcoming earnings report date is Feb 22, 2024 which is in 86 days.
      How were Ionis Pharmaceuticals’s earnings last quarter?
      Ionis Pharmaceuticals released its earnings results on Nov 02, 2023. The company reported -$1.03 earnings per share for the quarter, missing the consensus estimate of -$1.008 by -$0.022.
        Is Ionis Pharmaceuticals overvalued?
        According to Wall Street analysts Ionis Pharmaceuticals’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Ionis Pharmaceuticals pay dividends?
          Ionis Pharmaceuticals does not currently pay dividends.
          What is Ionis Pharmaceuticals’s EPS estimate?
          Ionis Pharmaceuticals’s EPS estimate is -$0.9.
            How many shares outstanding does Ionis Pharmaceuticals have?
            Ionis Pharmaceuticals has 143,472,120 shares outstanding.
              What happened to Ionis Pharmaceuticals’s price movement after its last earnings report?
              Ionis Pharmaceuticals reported an EPS of -$1.03 in its last earnings report, missing expectations of -$1.008. Following the earnings report the stock price went down -3.38%.
                Which hedge fund is a major shareholder of Ionis Pharmaceuticals?
                Among the largest hedge funds holding Ionis Pharmaceuticals’s share is Tweedy Browne CO LLC. It holds Ionis Pharmaceuticals’s shares valued at 159M.


                  Company Description

                  Ionis Pharmaceuticals

                  Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core and Akcea Therapeutics segments. The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs. The Akcea Therapeutics segment develops and commercializes drugs for cardiometabolic diseases. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli and Brett P. Monia in 1989 and is headquartered in Carlsbad, CA.


                  Top 5 ETFs holding IONS

                  Market Value
                  Smart Score
                  Vanguard Total Stock Market ETF
                  Vanguard Health Care ETF
                  Vanguard Russell 1000 Growth ETF
                  Vanguard Russell 1000 ETF
                  Vanguard Russell 3000 ETF
                  Up to five ETFs with an Outperform Smart Score that hold IONS. The ETFs are listed according to market value of IONS within the ETF

                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Alnylam Pharma
                  Arrowhead Pharmaceuticals
                  Intellia Therapeutics

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis